CoMind Early Feasibility Study
NCT06368648
Autoregulation, Brain Diseases
Sacramento, California, United States
View Trial DetailsNCT Number: NCT07830927
This prospective cohort study aims to identify baseline clinical, laboratory, and radiological factors at admission that are associated with early neurological outcomes in children with encephalitis admitted to Assiut University Children Hospital.
Trial opening soon.
Get Notified1 month–12 year
All sexes
Observational
Encephalitis in children carries a high risk of neurological sequelae. This observational study will include children aged 1 month to 12 years with possible or probable encephalitis according to the International Encephalitis Consortium 2013 case definition.
Baseline clinical, laboratory, neuroimaging, and EEG findings will be recorded. Early neurological outcome will be assessed at hospital discharge using the pediatric modified Rankin Scale (mRS).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 30 days
Score on the pediatric modified Rankin Scale at hospital discharge. The scale ranges from 0 (no symptoms) to 6 (death), with higher scores indicating worse functional outcome
Time frame: Up to 30 days
Length of hospital stay in days.
Time frame: Up to 30 days
Number of children who require intensive care unit admission
Time frame: Up to 30 days
Number of children who require nasogastric tube feeding at the time of hospital discharge
Time frame: Up to 30 days
Number of children who develop nosocomial infections during hospitalization
Trial opening soon.
Get NotifiedAssiut University
Other
Predictors of Early Neurological Outcome in Children With Encephalitis: A Prospective Study From Assiut University Children Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06368648
Autoregulation, Brain Diseases
Sacramento, California, United States
View Trial DetailsNCT03710278
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Spartanburg, South Carolina, United States
View Trial DetailsNCT07241858
Brain Diseases, Central Nervous System Diseases
Asyut, Asyut Governorate, Egypt
View Trial DetailsNCT06849011
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial Details